
Ajooni Biotech (AJOONI) | Stock Overview & Key Data
Ajooni Biotech Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹85.85 on February 7, 2022
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
No peer performance data available for this stock.
Ownership & Short Interest
Ajooni Biotech Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Ajooni Biotech would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is AJOONI's 52-week high and low?
In the last 52 weeks, Ajooni Biotech reached a high of ₹10.34 (on September 4, 2024) and a low of ₹5.24 (on April 7, 2025).
What is the market cap and P/E ratio for AJOONI?
Curious about Ajooni Biotech's size and valuation? Its market capitalization stands at 555.49M. When it comes to valuation, the P/E ratio (trailing twelve months) is 25.41, and the forward P/E (looking ahead) is N/A.
Does AJOONI pay dividends? If so, what's the yield?
As for dividends, Ajooni Biotech isn't currently offering a significant yield, or that specific data isn't available right now.
Who are Ajooni Biotech's main competitors or similar companies to consider before investing?
When looking at Ajooni Biotech, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
No specific competitor data is currently available for comparison in this section.
What are the key financial health indicators for Ajooni Biotech Ltd.? (e.g., ROE, Debt/Equity)
To get a sense of Ajooni Biotech's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.27%, the Debt to Equity ratio from the most recent quarter is 2.36, and its Gross Profit Margin stands at 20.93%.
What is the recent revenue and earnings growth for AJOONI?
Looking at Ajooni Biotech's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 69.70%, and quarterly earnings saw a YoY growth of 66.00%.
How much of AJOONI stock is held by insiders and institutions?
Wondering who owns Ajooni Biotech stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.